Select a community
All Communities
Home > Community Treatment Reports > Mucinex (guaifenesin) Treatment Report
What is Mucinex?

Mucinex is a brand name for the drug guaifenesin. Mucinex is an expectorant, meaning it helps with bringing up phlegm and other secretions from the throat and lungs. It is available in extended release formulas. Read more...Click to read more below

Adams Respiratory Therapeutics's Mucinex site

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
0 0%
Mild
0 0%
None
4 100%

Dosages

Top 10 dosages based on patients currently taking Mucinex. See all 15 dosages

  420mg as needed 600mg as needed as needed daily 2 daily 6 tbs. daily 30 mg daily 100 mg daily 400 mg daily 600 daily 600 mg daily 800 mg daily 1200 mg daily 1800 mg daily 2400 mg daily
  1 Number of Patients: 1 4 Number of Patients: 4 1 Number of Patients: 1 2 Number of Patients: 2 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 10 Number of Patients: 10 1 Number of Patients: 1 10 Number of Patients: 10 1 Number of Patients: 1 2 Number of Patients: 2  

Stop Reasons

Why Patients Stopped Taking Mucinex (multiple reasons could be selected)
Reason # Patients Percentage of patients
Other
3 43% Other: 43%
Course of treatment ended
2 29% Course of treatment ended: 29%

See all 5 patients who’ve stopped taking Mucinex

Currently Taking Mucinex

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
3
4
4
8

Stopped Taking Mucinex

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
1
2
1
1
0

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
4 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
3 75%
Not at all
1 25%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
1 25%
$25-49
0 0%
< $25
2 50%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 21, 2009.